Initiated coverage positions by the Dutch Healthcare Institute as of June 2026

The Dutch Healthcare Institute performs health technology assessments to inform decisions about the coverage status of pharmaceutical and non-pharmaceutical medical technologies. Procedures are reviewed according to the criteria of necessity, effectiveness (conformity with “state of science and practice”), cost-effectiveness, and feasibility (later, only in case of review before the implementation of the method). The Ministry of Health, Welfare, and Sport makes a final coverage decision based on the recommendations provided by the ZIN.

As of June 2026, the Dutch Healthcare Institute (ZIN) initiated two new coverage positions:

• Assessment of spinal cord stimulation for chronic back and leg pain for patients with Persistent Spinal Pain Syndrome Type 1 (PSPS-T1) following insufficient results from standard care. The publication of the Position is expected in the first quarter of 2027;
• Assessment of bihormonal artificial pancreas for patients with type 1 diabetes based on the study's research results, funded under the Promising Care program. The publication of the Position is scheduled for October 2026.

This news is just one of about 300 market access news and updates collected by our team in the premium subscription service MTRC Access Intelligence every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-weeks, no-obligation trial.